NCT05373251 PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer Status NOT_YET_RECRUITING Phase NA
NCT05366881 cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease Status RECRUITING Phase N/A
NCT05364918 Clinical Study On Acute Radiotherapy-Induced Oral Mucositis In Patients With Locally Advanced Head And Neck Tumors Status COMPLETED Phase PHASE3
NCT05328024 Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma Status RECRUITING Phase N/A
NCT05327270 Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05325970 Clinical Registry of Long-Term Dental Outcomes in Head and Neck Cancer Patients Status COMPLETED Phase N/A
NCT05322135 A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma Status TERMINATED Phase EARLY_PHASE1
NCT05318027 ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05313191 Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors Status RECRUITING Phase NA
NCT05312710 Safety and Efficacy of APG-157 in Head and Neck Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05287113 Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05273307 Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05271604 A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT05269342 Nurse-led Exercise Improves Shoulder Pain, Shoulder Disability, and Quality of Life in Head and Neck Cancer Status COMPLETED Phase NA
NCT05265013 ASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With or Without Metastases Status TERMINATED Phase PHASE2